http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2715883-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_924b3e0c5dd6c8ed563ab5d53fda1494
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2018-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9778a170664b62e5c159748808b52a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b45135b3aa45f49dcdd40083a42d15
publicationDate 2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2715883-C2
titleOfInvention Method for assessment of athletes adaptation potential
abstract FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to laboratory diagnostics, and discloses a method for assessment of athletes adaptation potential. Method involves blood serum measurement by immunoenzymometric analysis of the level of antibodies to endogenous bioregulators selected from a group β-endorphin, orphanin, serotonin, dopamine, histamine, angiotensin, glutamate and gamma-aminobutyric acid, calculating an adaptation value in standard units for the level of antibodies of each endogenous bioregulator by dividing the difference value of the optical density of the analyzed sample and the average value of the optical density of blood serum samples of healthy donors, selected from the average statistical group of people of the same age and sex with the tested sportspeople engaged in recreational physical training, on the group average value of the optical density of blood serum samples of healthy donors. Results of calculating an adaptation index are used to evaluate a condition of a sportsman as: overtraining, state of under-training, the end of the recovery period or the peak of the form.EFFECT: invention can be used in sports medicine to determine and evaluate biological reserves of body adaptation to physical activity.1 cl, 4 tbl, 4 ex
priorityDate 2018-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010119821-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2495433-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543571
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18976
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID380532
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57339188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971072
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01203
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5443
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775

Total number of triples: 46.